Rafael A Rodriguez, MD
Pathology · Woodland
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Offices
- 6
Offices
6 locations · Lucent Pathology Partners Inc · Associated Pathology Medical Group Inc · Regents of the Univ of CA
Looking this up.
Hospitals listed: Mercy Hospital of Folsom · Mercy San Juan Medical Center · University of California Davis Medical Center · Woodland Memorial Hospital. That is not proof they admit you there this week.
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Dr. Rodriguez’s office to ask if they take your plan before you enroll.
California Medical Board record
Licence A85779 · Current
Licensed to practise in California · since 2004 · expires 2027-12-31 · University of California, Davis School of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Hospitals they work in
4 hospitals
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Mercy Hospital of FolsomFolsom, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of CommonSpirit Health, which runs 145 hospitals in 19 statesPatients rate it 3 of 5 · 75% would definitely recommend itOverall rating: 4 of 5 starsBetter than the national rate — Clostridium Difficile (C.Diff): 0.102, Oct 2024 – Sep 2025
- Mercy San Juan Medical CenterCarmichael, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of CommonSpirit Health, which runs 145 hospitals in 19 statesPatients rate it 3 of 5 · 69% would definitely recommend itOverall rating: 3 of 5 starsBetter than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.108, Oct 2024 – Sep 2025Better than the national rate — MRSA Bacteremia: 0.144, Oct 2024 – Sep 2025
- University of California Davis Medical CenterSacramento, CAAcute Care Hospital · Government - Hospital District or Authority · Has an emergency department · Birthing-friendlyPart of University of California Health, which runs 12 hospitalsHome of UC Davis Comprehensive Cancer Center, a National Cancer Institute designated comprehensive cancer centrePatients rate it 3 of 5 · 74% would definitely recommend itOverall rating: 4 of 5 starsWorse than the national rate — Abdominopelvic accidental puncture or laceration rate: 1.94 (1.18 to 2.71) · 3,010 cases, Jul 2022 – Jun 2024Worse than the national rate — MRSA Bacteremia: 1.564, Oct 2024 – Sep 2025Worse than the national rate — Rate of emergency department (ED) visits for patients receiving outpatient chemotherapy: 6.7 (5.6 to 8) · 1,134 cases, Jan 2024 – Dec 2024Worse than the national rate — Rate of inpatient admissions for patients receiving outpatient chemotherapy: 12.6 (10.9 to 14.5) · 1,134 cases, Jan 2024 – Dec 2024Better than the national rate — Death rate among surgical inpatients with serious treatable complications: 127.46 (95.81 to 159.1) · 281 cases, Jul 2022 – Jun 2024Better than the national rate — Pressure ulcer rate: 0.18 (0 to 0.57) · 12,625 cases, Jul 2022 – Jun 2024Better than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.677, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.713, Oct 2024 – Sep 2025Better than the national rate — Ratio of unplanned hospital visits after hospital outpatient surgery: 0.8 (0.7 to 1) · 2,436 cases, Jan 2024 – Dec 2024
- Woodland Memorial HospitalWoodland, CAAcute Care Hospital · Voluntary non-profit - Other · Has an emergency department · Birthing-friendlyPart of CommonSpirit Health, which runs 145 hospitals in 19 statesPatients rate it 4 of 5 · 71% would definitely recommend itOverall rating: 5 of 5 starsNo measure marked better or worse than the national rate
See every measure and the patient survey for Mercy Hospital of Folsom
Behind the star rating — Deaths: 0 better, 7 the same, 0 worse of 7 measures. Safety: 1 better, 6 the same, 0 worse of 7 measures. Readmissions: 0 better, 5 the same, 2 worse of 7 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Clostridium Difficile (C.Diff)Infections | 0.102 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.95 (0 to 1.99) · 563 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.96 (0.55 to 1.37) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 175.63 (113.7 to 237.56) · 25 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for COPD patientsComplications and deaths | 9.2 · 113 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 12.3 · 29 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 9.9 · 301 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 13.6 · 320 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 13.8 · 150 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.5 · 1,324 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.19 (0 to 0.41) · 3,820 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.24 (0.04 to 0.45) · 3,797 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.56 (1.22 to 5.9) · 554 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.65 (0 to 3.37) · 213 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.46 (0.79 to 4.12) · 524 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 12.8 (3.44 to 22.16) · 214 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 4.88 (0.69 to 9.07) · 201 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.7 (0.2 to 3.2) · 197 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.27 (0 to 1.15) · 3,045 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 4.3 · 66 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 1.279 | No different | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 1.434 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 1.368 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 1.311 | No different | Oct 2024 – Sep 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 23.3 · 334 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 7.9 · 324 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | -19.4 · 321 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 17 · 321 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.5 · 59 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.1 · 146 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.3 (9.9 to 18) · 89 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.9 (0.7 to 1.3) · 155 cases | No different | Jan 2024 – Dec 2024 |
What patients said (647 patients answered, 19% of those asked)
| Cleanliness | 3 |
| Nurse communication | 4 |
| Doctor communication | 3 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 2 |
| Recommend hospital | 4 |
| Room was "always" clean | 69% |
| Nurses "always" communicated well | 79% |
| Doctors "always" communicated well | 79% |
| Staff "always" explained | 62% |
| Yes, staff "did" give patients this information | 90% |
| Yes, staff "did" give patients information about help after discharge | 90% |
| Doctors "always" explained things so they could understand | 72% |
| Doctors "always" listened carefully | 76% |
| Doctors "always" treated them with courtesy and respect | 88% |
| Patients who gave a rating of "9" or "10" (high) | 73% |
| Staff "always" explained new medications | 76% |
| Nurses "always" explained things so they could understand | 74% |
| Nurses "always" listened carefully | 76% |
| Nurses "always" treated them with courtesy and respect | 88% |
| "Always" quiet at night | 47% |
| "YES", patients would definitely recommend the hospital | 75% |
| Staff "always" explained possible side effects | 48% |
| Yes, staff "did" give patients information about possible symptoms | 91% |
See every measure and the patient survey for Mercy San Juan Medical Center
Behind the star rating — Deaths: 0 better, 8 the same, 0 worse of 8 measures. Safety: 2 better, 5 the same, 0 worse of 7 measures. Readmissions: 1 better, 8 the same, 2 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.108 | Better | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.144 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.78 (0 to 1.72) · 1,413 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.77 (0.47 to 1.07) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 195.56 (150.94 to 240.19) · 122 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 1.9 · 45 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 9.6 · 193 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 14.6 · 190 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 12.9 · 445 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 13.7 · 444 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 12.2 · 518 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.7 · 3,727 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.19 (0 to 0.39) · 8,263 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.23 (0.05 to 0.42) · 8,488 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 2.3 (0.42 to 4.18) · 1,992 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.38 (0 to 2.95) · 566 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.08 (0.71 to 3.44) · 1,929 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 6.41 (0 to 13) · 533 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 4.3 (0.68 to 7.92) · 557 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.6 (0.14 to 3.06) · 338 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.53 (0 to 1.11) · 7,155 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 4.3 · 48 cases | None | Apr 2023 – Mar 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.567 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 15.1 · 283 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 22.2 · 852 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 1.4 · 183 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -14.6 · 522 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | -12.4 · 458 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 17.9 · 708 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 4.9 (3.1 to 7.5) · 102 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 10 (7 to 14) · 102 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 6.1 · 57 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 11.3 · 51 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 21.2 · 379 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.8 (9.5 to 17.2) · 384 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1.1 (0.8 to 1.4) · 291 cases | No different | Jan 2024 – Dec 2024 |
What patients said (611 patients answered, 17% of those asked)
| Cleanliness | 3 |
| Nurse communication | 3 |
| Doctor communication | 3 |
| Communication about medicines | 3 |
| Discharge information | 3 |
| Overall hospital rating | 3 |
| Quietness | 2 |
| Recommend hospital | 4 |
| Room was "always" clean | 64% |
| Nurses "always" communicated well | 77% |
| Doctors "always" communicated well | 77% |
| Staff "always" explained | 63% |
| Yes, staff "did" give patients this information | 86% |
| Yes, staff "did" give patients information about help after discharge | 86% |
| Doctors "always" explained things so they could understand | 72% |
| Doctors "always" listened carefully | 74% |
| Doctors "always" treated them with courtesy and respect | 85% |
| Patients who gave a rating of "9" or "10" (high) | 68% |
| Staff "always" explained new medications | 75% |
| Nurses "always" explained things so they could understand | 75% |
| Nurses "always" listened carefully | 72% |
| Nurses "always" treated them with courtesy and respect | 84% |
| "Always" quiet at night | 41% |
| "YES", patients would definitely recommend the hospital | 69% |
| Staff "always" explained possible side effects | 50% |
| Yes, staff "did" give patients information about possible symptoms | 86% |
See every measure and the patient survey for University of California Davis Medical Center
Behind the star rating — Deaths: 4 better, 4 the same, 0 worse of 8 measures. Safety: 0 better, 7 the same, 1 worse of 8 measures. Readmissions: 0 better, 9 the same, 2 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.94 (1.18 to 2.71) · 3,010 cases | Worse | Jul 2022 – Jun 2024 |
| MRSA BacteremiaInfections | 1.564 | Worse | Oct 2024 – Sep 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 6.7 (5.6 to 8) · 1,134 cases | Worse | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 12.6 (10.9 to 14.5) · 1,134 cases | Worse | Jan 2024 – Dec 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 127.46 (95.81 to 159.1) · 281 cases | Better | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.18 (0 to 0.57) · 12,625 cases | Better | Jul 2022 – Jun 2024 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.677 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.713 | Better | Oct 2024 – Sep 2025 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.8 (0.7 to 1) · 2,436 cases | Better | Jan 2024 – Dec 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.98 (0.78 to 1.19) | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.2 · 82 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 7.2 · 165 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 11.2 · 115 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 9.7 · 662 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 10.1 · 463 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 10.1 · 406 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.9 · 4,328 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.22 (0.05 to 0.39) · 13,828 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.3 (0.13 to 0.46) · 14,152 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 4.29 (2.92 to 5.66) · 4,920 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.78 (0.46 to 3.09) · 2,250 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.07 (1.06 to 3.09) · 4,696 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 9.46 (5.18 to 13.75) · 2,102 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 6.35 (3.74 to 8.96) · 2,191 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 2.48 (1.19 to 3.77) · 1,169 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 4.3 · 127 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.826 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0.899 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.669 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 14.2 · 131 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 21.2 · 751 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | -25.8 · 127 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 24.1 · 758 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 23.6 · 477 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 17.6 · 469 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.7 · 140 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 10.9 · 65 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 18.3 · 203 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 11.8 (9.4 to 14.9) · 2,643 cases | No different | Jan 2022 – Dec 2024 |
What patients said (2,768 patients answered, 18% of those asked)
| Cleanliness | 2 |
| Nurse communication | 3 |
| Doctor communication | 3 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 3 |
| Quietness | 1 |
| Recommend hospital | 4 |
| Room was "always" clean | 61% |
| Nurses "always" communicated well | 76% |
| Doctors "always" communicated well | 78% |
| Staff "always" explained | 60% |
| Yes, staff "did" give patients this information | 89% |
| Yes, staff "did" give patients information about help after discharge | 89% |
| Doctors "always" explained things so they could understand | 72% |
| Doctors "always" listened carefully | 76% |
| Doctors "always" treated them with courtesy and respect | 85% |
| Patients who gave a rating of "9" or "10" (high) | 68% |
| Staff "always" explained new medications | 73% |
| Nurses "always" explained things so they could understand | 71% |
| Nurses "always" listened carefully | 74% |
| Nurses "always" treated them with courtesy and respect | 84% |
| "Always" quiet at night | 37% |
| "YES", patients would definitely recommend the hospital | 74% |
| Staff "always" explained possible side effects | 47% |
| Yes, staff "did" give patients information about possible symptoms | 89% |
See every measure and the patient survey for Woodland Memorial Hospital
Behind the star rating — Deaths: 0 better, 5 the same, 0 worse of 5 measures. Safety: 0 better, 5 the same, 0 worse of 5 measures. Readmissions: 1 better, 7 the same, 0 worse of 8 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.99 (0 to 2.04) · 255 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.03 (0.59 to 1.48) | No different | Jul 2022 – Jun 2024 |
| Death rate for COPD patientsComplications and deaths | 8.4 · 55 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 14 · 76 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 16.8 · 102 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 9.3 · 85 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.8 · 699 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.19 (0 to 0.42) · 1,388 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.26 (0.05 to 0.47) · 1,448 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.13 (0.63 to 5.63) · 220 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.65 (0 to 3.38) · 86 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.23 (0.54 to 3.93) · 213 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 8.45 (0 to 18.11) · 86 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.9 (1.66 to 10.15) · 76 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 2.05 (0.54 to 3.56) · 101 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.84 (0 to 1.88) · 1,075 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 4 · 26 cases | None | Apr 2023 – Mar 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0 | No different | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.242 | No different | Oct 2024 – Sep 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20.7 · 112 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -42.4 · 84 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 4.4 · 105 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.8 · 116 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.6 (3.7 to 8.2) · 84 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 11.6 (8.5 to 15.8) · 84 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.8 · 28 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 18.7 · 69 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 11.8 (8.9 to 15.7) · 926 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1.3 (1 to 1.8) · 227 cases | No different | Jan 2024 – Dec 2024 |
What patients said (302 patients answered, 17% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 4 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 2 |
| Recommend hospital | 4 |
| Room was "always" clean | 70% |
| Nurses "always" communicated well | 81% |
| Doctors "always" communicated well | 85% |
| Staff "always" explained | 66% |
| Yes, staff "did" give patients this information | 90% |
| Yes, staff "did" give patients information about help after discharge | 90% |
| Doctors "always" explained things so they could understand | 82% |
| Doctors "always" listened carefully | 84% |
| Doctors "always" treated them with courtesy and respect | 88% |
| Patients who gave a rating of "9" or "10" (high) | 72% |
| Staff "always" explained new medications | 82% |
| Nurses "always" explained things so they could understand | 76% |
| Nurses "always" listened carefully | 80% |
| Nurses "always" treated them with courtesy and respect | 87% |
| "Always" quiet at night | 43% |
| "YES", patients would definitely recommend the hospital | 71% |
| Staff "always" explained possible side effects | 51% |
| Yes, staff "did" give patients information about possible symptoms | 90% |
Original Medicare doctor bills
$117,567
Medicare paid this office $117,567 for 1,368 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Pathology examination of tissue using a microscope, intermediate complexity | 1,043 | $54,656 | $29 |
| Pathology examination of tissue using a microscope, moderately high complexity | 144 | $17,174 | $67 |
| Special stained specimen slides to examine tissue, each additional procedure | 136 | $12,789 | $23 |
| Pathology examination of specimen during surgery, first tissue block | 85 | $6,490 | $51 |
| Special stained specimen slides to examine tissue, initial procedure | 176 | $5,342 | $28 |
See all 14 services
| Pathology examination of tissue using a microscope, intermediate complexity | 1,043 | $54,656 | $29 |
| Pathology examination of tissue using a microscope, moderately high complexity | 144 | $17,174 | $67 |
| Special stained specimen slides to examine tissue, each additional procedure | 136 | $12,789 | $23 |
| Pathology examination of specimen during surgery, first tissue block | 85 | $6,490 | $51 |
| Special stained specimen slides to examine tissue, initial procedure | 176 | $5,342 | $28 |
| Pathology examination of tissue using a microscope, intermediate complexity | 37 | $5,141 | $49 |
| Preparation of tissue for examination by removing any calcium present | 234 | $2,621 | $10 |
| Pathology examination of tissue using a microscope, high complexity | 17 | $2,266 | $119 |
| Microscopic genetic analysis of tumor, manual | 14 | $1,737 | $33 |
| Pathology examination of tissue using a microscope, moderately low complexity | 146 | $1,547 | $9 |
| Special stained specimen slides to identify organisms including interpretation and report | 23 | $1,184 | $22 |
| Special stained specimen slides to examine tissue including interpretation and report | 20 | $317 | $10 |
| Pathology examination of tissue using a microscope | 38 | $224 | $6 |
| Pathology examination of tissue using a microscope, limited examination | 28 | $112 | $4 |
Who their Medicare patients are
1,368 Original Medicare patients in 2024. Average age 73 · Under 65 9% · 85 and older 10% · Women 55% · Also on Medicaid 31% · Health risk score 1.44. At or below the middle of the specialty; the typical pathology clinician is at 1.55.
Conditions among them: High blood pressure 75% · Diabetes 34% · Cancer 27% · Coronary heart disease 24% · Chronic kidney disease 23% · Depression 23% · Atrial fibrillation 20% · COPD 17% · Heart failure 16% · Stroke 8% · Dementia 7%.
The office billed $510,214, Medicare allowed $151,282 and paid $117,567; for 3,858 services of 24 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 1,368 | 3,858 | 73 | 1.44 | $510,214 | $117,567 |
| 2023 | 772 | 2,076 | 72 | 1.19 | $316,325 | $68,652 |
| 2022 | 733 | 1,975 | 72 | 1.23 | $257,534 | $60,892 |
| 2021 | 848 | 2,350 | 72 | 1.20 | $302,078 | $72,051 |
| 2020 | 620 | 1,668 | 71 | 1.31 | $208,181 | $52,285 |
| 2019 | 958 | 2,570 | 71 | 1.15 | $329,026 | $78,353 |
| 2018 | 910 | 2,324 | 71 | 1.14 | $345,048 | $81,238 |
| 2017 | 1,165 | 2,887 | 70 | 1.11 | $472,322 | $113,922 |
| 2016 | 661 | 1,640 | 70 | 1.23 | $205,982 | $49,509 |
| 2015 | 660 | 1,636 | 70 | 1.21 | $203,792 | $49,213 |
| 2014 | 132 | 270 | 70 | 0.94 | $34,998 | $8,212 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 12 services
| Pathology examination of tissue using a microscope, intermediate complexity | 582 | $31,698 | $29 |
| Pathology examination of tissue using a microscope, moderately high complexity | 83 | $11,025 | $67 |
| Special stained specimen slides to examine tissue, each additional procedure | 58 | $4,981 | $23 |
| Pathology examination of tissue using a microscope, intermediate complexity | 32 | $4,398 | $45 |
| Pathology examination of specimen during surgery, first tissue block | 58 | $3,942 | $51 |
| Surgical pathology, gross and microscopic examinations, for prostate needle biopsy, any method | 19 | $2,780 | $146 |
| Special stained specimen slides to examine tissue, initial procedure | 82 | $2,552 | $29 |
| Pathology examination of tissue using a microscope, high complexity | 18 | $2,151 | $120 |
| Preparation of tissue for examination by removing any calcium present | 90 | $943 | $10 |
| Special stained specimen slides to examine tissue, initial procedure | 11 | $848 | $77 |
| Pathology examination of tissue using a microscope, moderately low complexity | 81 | $818 | $9 |
| Pathology examination of tissue using a microscope | 12 | $84 | $5 |
2022: 12 services
| Pathology examination of tissue using a microscope, intermediate complexity | 576 | $32,897 | $28 |
| Pathology examination of tissue using a microscope, moderately high complexity | 58 | $7,395 | $68 |
| Pathology examination of tissue using a microscope, intermediate complexity | 39 | $5,213 | $55 |
| Special stained specimen slides to examine tissue, each additional procedure | 53 | $4,892 | $23 |
| Pathology examination of specimen during surgery, first tissue block | 39 | $2,382 | $52 |
| Special stained specimen slides to examine tissue, initial procedure | 74 | $2,314 | $29 |
| Pathology examination of tissue using a microscope, high complexity | 16 | $2,058 | $121 |
| Special stained specimen slides to examine tissue, initial procedure | 14 | $1,140 | $81 |
| Preparation of tissue for examination by removing any calcium present | 84 | $909 | $10 |
| Pathology examination of tissue using a microscope, moderately low complexity | 63 | $586 | $9 |
| Pathology examination of tissue using a microscope | 17 | $85 | $5 |
| Pathology examination of tissue using a microscope, limited examination | 12 | $44 | $4 |
2021: 11 services
| Pathology examination of tissue using a microscope, intermediate complexity | 729 | $45,501 | $30 |
| Pathology examination of tissue using a microscope, moderately high complexity | 69 | $7,271 | $69 |
| Pathology examination of specimen during surgery, first tissue block | 56 | $4,516 | $53 |
| Special stained specimen slides to examine tissue, each additional procedure | 57 | $4,093 | $24 |
| Special stained specimen slides to examine tissue, initial procedure | 93 | $2,754 | $29 |
| Pathology examination of tissue using a microscope, high complexity | 19 | $2,346 | $123 |
| Pathology examination of tissue using a microscope, intermediate complexity | 17 | $1,937 | $37 |
| Preparation of tissue for examination by removing any calcium present | 117 | $1,289 | $10 |
| Pathology examination of tissue using a microscope, moderately low complexity | 63 | $623 | $9 |
| Special stained specimen slides to identify organisms including interpretation and report | 19 | $496 | $22 |
| Pathology examination of tissue using a microscope | 19 | $98 | $5 |
2020: 11 services
| Pathology examination of tissue using a microscope, intermediate complexity | 528 | $33,403 | $31 |
| Pathology examination of tissue using a microscope, moderately high complexity | 43 | $5,417 | $72 |
| Special stained specimen slides to examine tissue, each additional procedure | 36 | $3,721 | $25 |
| Pathology examination of specimen during surgery, first tissue block | 45 | $3,056 | $55 |
| Special stained specimen slides to examine tissue, initial procedure | 65 | $2,000 | $30 |
| Pathology examination of tissue using a microscope, high complexity | 13 | $1,775 | $127 |
| Preparation of tissue for examination by removing any calcium present | 94 | $1,098 | $11 |
| Pathology examination of tissue using a microscope, moderately low complexity | 44 | $474 | $10 |
| Special stained specimen slides to identify organisms including interpretation and report | 11 | $349 | $23 |
| Pathology examination of tissue using a microscope | 17 | $119 | $6 |
| Pathology examination of tissue using a microscope, limited examination | 15 | $53 | $4 |
2019: 9 services
| Pathology examination of tissue using a microscope, intermediate complexity | 853 | $60,322 | $32 |
| Pathology examination of tissue using a microscope, moderately high complexity | 41 | $4,887 | $72 |
| Special stained specimen slides to examine tissue, initial procedure | 101 | $3,783 | $31 |
| Special stained specimen slides to examine tissue, each additional procedure | 38 | $3,494 | $25 |
| Pathology examination of specimen during surgery, first tissue block | 32 | $2,063 | $54 |
| Preparation of tissue for examination by removing any calcium present | 115 | $1,302 | $11 |
| Pathology examination of tissue using a microscope, moderately low complexity | 69 | $761 | $10 |
| Special stained specimen slides to examine tissue including interpretation and report | 13 | $217 | $9 |
| Pathology examination of tissue using a microscope | 27 | $176 | $6 |
2018: 13 services
| Pathology examination of tissue using a microscope, intermediate complexity | 669 | $43,426 | $31 |
| Pathology examination of tissue using a microscope, intermediate complexity | 145 | $14,581 | $49 |
| Special stained specimen slides to identify organisms including interpretation and report | 76 | $7,594 | $83 |
| Pathology examination of tissue using a microscope, moderately high complexity | 39 | $4,788 | $71 |
| Special stained specimen slides to examine tissue, initial procedure | 74 | $2,460 | $30 |
| Special stained specimen slides to examine tissue, each additional procedure | 25 | $2,187 | $24 |
| Pathology examination of specimen during surgery, first tissue block | 27 | $1,843 | $54 |
| Preparation of tissue for examination by removing any calcium present | 80 | $959 | $11 |
| Pathology examination of tissue using a microscope, moderately low complexity | 52 | $564 | $10 |
| Special stained specimen slides to identify organisms including interpretation and report | 14 | $402 | $22 |
| Special stained specimen slides to examine tissue including interpretation and report | 15 | $346 | $10 |
| Pathology examination of tissue using a microscope | 19 | $115 | $6 |
| Pathology examination of tissue using a microscope, limited examination | 19 | $78 | $4 |
2017: 12 services
| Pathology examination of tissue using a microscope, intermediate complexity | 707 | $41,566 | $30 |
| Pathology examination of tissue using a microscope, intermediate complexity | 344 | $39,960 | $57 |
| Special stained specimen slides to identify organisms including interpretation and report | 166 | $14,891 | $81 |
| Pathology examination of tissue using a microscope, moderately high complexity | 49 | $5,487 | $68 |
| Pathology examination of specimen during surgery, first tissue block | 40 | $2,627 | $52 |
| Special stained specimen slides to examine tissue, initial procedure | 70 | $2,353 | $29 |
| Special stained specimen slides to examine tissue, each additional procedure | 18 | $1,302 | $23 |
| Preparation of tissue for examination by removing any calcium present | 101 | $1,187 | $10 |
| Pathology examination of tissue using a microscope, moderately low complexity | 88 | $890 | $9 |
| Special stained specimen slides to identify organisms including interpretation and report | 17 | $619 | $22 |
| Pathology examination of tissue using a microscope | 19 | $105 | $6 |
| Pathology examination of tissue using a microscope, limited examination | 16 | $57 | $4 |
2016: 8 services
| Pathology examination of tissue using a microscope, intermediate complexity | 588 | $35,590 | $30 |
| Pathology examination of tissue using a microscope, moderately high complexity | 33 | $3,826 | $68 |
| Pathology examination of specimen during surgery, first tissue block | 33 | $2,221 | $52 |
| Special stained specimen slides to examine tissue, each additional procedure | 25 | $2,030 | $22 |
| Special stained specimen slides to examine tissue, initial procedure | 56 | $1,721 | $29 |
| Preparation of tissue for examination by removing any calcium present | 71 | $800 | $11 |
| Pathology examination of tissue using a microscope, moderately low complexity | 50 | $469 | $9 |
| Pathology examination of tissue using a microscope | 11 | $65 | $6 |
2015: 8 services
| Pathology examination of tissue using a microscope, intermediate complexity | 524 | $34,148 | $31 |
| Pathology examination of tissue using a microscope, moderately high complexity | 40 | $4,994 | $70 |
| Pathology examination of specimen during surgery, first tissue block | 30 | $2,219 | $53 |
| Special stained specimen slides to examine tissue, each additional procedure | 24 | $1,602 | $18 |
| Special stained specimen slides to examine tissue, initial procedure | 46 | $1,461 | $29 |
| Pathology examination of tissue using a microscope, moderately low complexity | 103 | $1,005 | $10 |
| Preparation of tissue for examination by removing any calcium present | 72 | $795 | $10 |
| Pathology examination of tissue using a microscope, limited examination | 18 | $67 | $4 |
2014: 4 services
| Pathology examination of tissue using a microscope, intermediate complexity | 95 | $5,872 | $31 |
| Pathology examination of tissue using a microscope, moderately high complexity | 12 | $1,231 | $68 |
| Pathology examination of tissue using a microscope, moderately low complexity | 24 | $222 | $9 |
| Preparation of tissue for examination by removing any calcium present | 13 | $142 | $10 |
Medicaid work
$14,633 in 2024
Medicaid paid $14,633 for 1,034 billed services this clinician did in 2024, up to 87 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| TISSUE EXAM BY PATHOLOGIST | 632 | $8,391 |
| TISSUE EXAM BY PATHOLOGIST | 87 | $3,576 |
| TISSUE EXAM BY PATHOLOGIST | 143 | $1,845 |
| Immunohistochemistry or immunocytochemistry, per specimen; initial single antibody stain procedure | 45 | $602 |
| DECALCIFICATION PROCEDURE | 127 | $218 |
| 2024 | 1,034 | 5 | 87 | $14,633 |
| 2023 | 703 | 3 | 59 | $12,204 |
| 2022 | 676 | 1 | 41 | $6,208 |
| 2021 | 1,034 | 3 | 44 | $16,133 |
| 2020 | 799 | 3 | 48 | $14,578 |
| 2019 | 672 | 1 | 41 | $18,281 |
| 2018 | 445 | 1 | 46 | $12,219 |
See the largest Medicaid services in earlier years
2023
| TISSUE EXAM BY PATHOLOGIST | 663 | $11,525 |
| TISSUE EXAM BY PATHOLOGIST | 27 | $367 |
| Immunohistochemistry or immunocytochemistry, per specimen; initial single antibody stain procedure | 13 | $312 |
2022
| TISSUE EXAM BY PATHOLOGIST | 676 | $6,208 |
2021
| TISSUE EXAM BY PATHOLOGIST | 988 | $15,792 |
| TISSUE EXAM BY PATHOLOGIST | 17 | $341 |
| TISSUE EXAM BY PATHOLOGIST | 29 | $0 |
2020
| TISSUE EXAM BY PATHOLOGIST | 773 | $14,009 |
| Immunohistochemistry or immunocytochemistry, per specimen; initial single antibody stain procedure | 13 | $398 |
| TISSUE EXAM BY PATHOLOGIST | 13 | $171 |
2019
| TISSUE EXAM BY PATHOLOGIST | 672 | $18,281 |
2018
| TISSUE EXAM BY PATHOLOGIST | 445 | $12,219 |
Money from drug and device companies
$91 in 2025
| 2025 | 3 | 3 | None | $91 |
| 2024 | 1 | 1 | None | $38 |
| 2023 | 1 | 1 | None | $25 |
| 2021 | 1 | 1 | None | $16 |
| 2019 | 2 | 16 | $2,730 | $4,424 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Hologic Sales and Service | Aptima | $41 | 1 payment
|
| Boston Scientific | Emblem Mri S-Icd | $29 | 1 payment
|
| Rigel Pharmaceuticals | Tavalisse | $21 | 1 payment
|
See all 3 published payments
| Boston Scientific | Meals · 2025-05-12 | Emblem Mri S-Icd | $29 |
| Rigel Pharmaceuticals | Meals · 2025-05-02 | Tavalisse | $21 |
| Hologic Sales and Service | Meals · 2025-01-29 | Aptima | $41 |
See earlier years (2024, 2023, 2021, 2019)
2024: $38
| Hologic Sales and Service | Aptima | $38 | 1 payment
|
2023: $25
| Boston Scientific | Emblem Mri S-Icd | $25 | 1 payment
|
2021: $16
| Hologic | Aptima | $16 | 1 payment
|
2019: $4,424
| Incyte | None | $4,363 | 12 payments
|
| Hologic | Thinprep | $60 | 4 payments
|
Checkups this office reported
Medicare did not publish checkup rates for this clinician.
- Medicare’s overall office score
- 88.3 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
Professional record
- NPI
- 1265483192
- Licence
- CA A85779California A85779: Current · expires 2027-12-31
- Trained
- University of California, Davis School of Medicine, 2002
- Group
- Lucent Pathology Partners Inc · Associated Pathology Medical Group Inc · Regents of the Univ of CA
- Gender
- Male
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 207ZP0101X (207ZP0101X)
- Mailing address
- P.O. Box 340850, Sacramento, CA, 95834
- NPI first listed
- 2006-05-15
- NPI last updated
- 2019-07-24
This is when the NPI record was last certified, not a medical board exam.